Tuesday, March 17, 2026

Tesla Soars as Trump Support Boosts Stock Prices

Tesla shares surged on news of Elon Musk's support for Trump, nearing a $1 trillion market cap amid expectations for regulatory approvals.

They Were Headed for the Moon—Then Everything Went Wrong

Apollo 13's mission faced disaster after an oxygen tank explosion, but the crew's ingenuity and teamwork led to their safe return.

Coupang’s Data Breach Fallout Hits Trade Politics: $514M Investor Loss Claim, 25% Tariff Talk, and a U.S. Class-Action Collision

The Coupang crisis from a data breach has led to a U.S.-Korea trade dispute, impacting stock prices and class-action lawsuits.

Tag: ABL Bio

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

How ABL Bio’s Grabody-B Revolutionizes siRNA Delivery: A Game-Changer for Brain Disease Treatment?

ABL Bio's Grabody-B technology effectively delivers siRNA across the blood-brain barrier, enhancing treatment for brain and systemic diseases.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Top News

- Our Sponsors Ad -

Follow us